Duesseldorf, April 25, 2018 – The distribution of a dividend of EUR 1.10 per share was approved at the Annual General Meeting of Gerresheimer AG held today in Duesseldorf. The MDAX-listed Group produces glass and plastic pharma and cosmetics packaging and products for safe and simple drug delivery such as insulin pens, inhalers and syringes.
“In the pharma and healthcare markets important to us, the year 2017 that we now look back on was characterized by uncertainty, above all as a result of developments in the US. I am confident that the global pharma markets will pick up again in the years ahead and that we will deliver sustained and profitable growth. It is important to us that our shareholders participate in our financial success. Accordingly, we are increasing the dividend for the seventh year in a row,” said Rainer Beaujean, Speaker of the Management Board and CFO of Gerresheimer AG, summing up at the Annual General Meeting.
The dividend has been increased by 4.8% to EUR 1.10 per dividend-entitled share. A dividend of EUR 1.05 per share was distributed in the prior year. The dividend will be paid out on April 30, 2018.
A large majority voted in favor of the resolution formally approving the acts of the Management Board and Supervisory Board in the financial year 2017. Deloitte GmbH Wirtschaftsprüfungsgesellschaft, Duesseldorf, was elected as auditor for the financial year 2018.
At today’s Annual General Meeting, 79.78% of the capital stock was represented. The detailed voting results on all items of the Annual General Meeting agenda are available here: Annual General Meeting
The speech delivered at the Annual General Meeting is available here: Annual General Meeting
The Annual Report is available here: Reports
About Gerresheimer
Gerresheimer is a leading global partner to the pharma and healthcare industries. The company’s special glass and plastic products contribute to health and well-being. Gerresheimer is a global organization with about 10,000 employees and manufacturing operations in the local markets, close to customers. With plants in Europe, North and South America and Asia Gerresheimer generates revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging products as well as convenient and safe drug delivery systems such as insulin pens, inhalers, pre-fillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, plus cosmetic packaging products.
